DIN 02322285 — SOLIRIS 10 MG
SOLIRIS is a solution of Eculizumab marketed by ALEXION PHARMA GMBH. The full Eculizumab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02322285
- Brand name
- SOLIRIS
- Active ingredient
- Eculizumab
- Strength
- 10 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- ALEXION PHARMA GMBH
- Health Canada status
- MARKETED
- Drug class
- Complement inhibitor (anti-C5 monoclonal antibody)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.